Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation
about
Targeting selectins and selectin ligands in inflammation and cancerMembrane trafficking of death receptors: implications on signallingTNF-α enhancement of CD62E mediates adhesion of non-small cell lung cancer cells to brain endothelium via CD15 in lung-brain metastasis.Role of cancer microenvironment in metastasis: focus on colon cancerSurvival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3.p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.The TNF-family cytokine TL1A inhibits proliferation of human activated B cellsCD44 and HCELL: preventing hematogenous metastasis at step 1.The effect of soluble E-selectin on tumor progression and metastasis.A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endotheliumExpression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis.A genetic variation of the p38β promoter region is correlated with an increased risk of sporadic colorectal cancerAltered tumor-cell glycosylation promotes metastasis.Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer.Metastasis review: from bench to bedside.Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.Sialic acids in cancer biology and immunity.DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.The role of death receptor 3 in the biological behavior of hepatocellular carcinoma cells.Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response.The Interaction of Selectins and PSGL-1 as a Key Component in Thrombus Formation and Cancer Progression.Regulation of sialyl Lewis antigen expression in colon cancer cells by sialidase NEU4.E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-α-activated human umbilical vein endothelial cells.p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription.Lupeol, a dietary triterpene, inhibited growth, and induced apoptosis through down-regulation of DR3 in SMMC7721 cells.CD15s/CD62E Interaction Mediates the Adhesion of Non-Small Cell Lung Cancer Cells on Brain Endothelial Cells: Implications for Cerebral Metastasis.The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells.p38 and JNK pathways control E-selectin-dependent extravasation of colon cancer cells by modulating miR-31 transcriptionE-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis.P-, but not E- or L-, selectin-mediated rolling adhesion persistence in hemodynamic flow diverges between metastatic and leukocytic cells.p38 activation induces production of miR-146a and miR-31 to repress E-selectin expression and inhibit transendothelial migration of colon cancer cells.Selectins in cancer immunity.MicroRNA-650 targets inhibitor of growth 4 to promote colorectal cancer progression via mitogen activated protein kinase signaling.
P2860
Q24658204-3943B8B6-3B30-4298-8F5C-110BB588C1B0Q26852802-FCF32739-E613-4AD2-9983-71EFB3BD9660Q27322618-6B50C39E-C369-4169-9E63-95EA05328524Q28239062-87305A14-F079-481F-9222-57E94E9FDE10Q33948715-797466BD-AFB3-449C-9427-9487DE6D4481Q34008781-1281D383-F066-440F-94AF-A4FF1EE133F2Q34658152-34DB953E-162E-48BA-9429-0732341E9880Q35376738-7FDE9035-5B17-4EB4-BCE0-311F55D88A84Q36028192-EA78244D-3374-405E-84CD-F59895F4A89FQ36476824-6CBF0833-712D-46A7-A2C6-3972AB06A874Q36544769-0FF1ABAC-FEBC-4226-B83B-B30DA7A2CEE8Q36756674-2791B14E-C20B-4C7A-9B8D-AD1F16FC3C0FQ37093408-BAC5C8B6-08E7-4736-9F3E-AF73F81DA73EQ37581540-DEFA0DBE-7818-4C21-91A6-6866610A3964Q38043456-F9CB55EA-BC6B-46C4-AC18-66AD5CCD714FQ38237985-A7ED9858-9442-4F1D-875E-2276805DB6BEQ38534313-E0153FD0-680A-4B40-81E7-DE1A646834F4Q38620799-6DA4E1B3-F120-418E-813B-1198774D40D3Q38808955-290085D6-F16E-4096-9EAD-8C6D71C7A84DQ38942768-E335623F-E2F4-46DB-B64B-474F8F73E701Q39274331-412A599F-38A4-4441-9D49-1A1B714CA28CQ39416910-8A703BC3-9B7D-4AF2-974A-C096AA0F75E1Q39552528-1758C4BC-B6AC-4FC5-BF3C-14FF9323AF7AQ39594713-1D9667FC-A321-4A50-8DCF-4B6B4B2CE542Q39864596-A499AF3E-87E4-4A60-9A5F-B0B9DEC6D7F4Q39880785-8FA1794E-7657-4388-880C-12A69872D838Q41182443-B6A66F01-8606-4F4F-9426-B0DCEBDDFECEQ41547499-F0E8FA1D-16A3-44D7-96F5-12FFF3ADF9A8Q42102878-DA4FECE9-FEEB-439A-9762-047743B28461Q42123362-0F09477E-B120-4CA8-976B-BC1800DD7701Q46673509-C71A45FA-79F8-43D3-9D8F-0DFEE604BEF2Q48103200-E33D4C3A-7FF6-4678-8DBD-7B3E9DA2DF2EQ49617012-B9DEE532-9EC9-46A4-899E-D2B1AAE39EB5Q55673135-4282AF41-B190-494A-8F3E-E8AD17735B98
P2860
Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Death receptor-3, a new E-Sele ...... ng p38 and ERK MAPK activation
@ast
Death receptor-3, a new E-Sele ...... ng p38 and ERK MAPK activation
@en
Death receptor-3, a new E-Sele ...... ng p38 and ERK MAPK activation
@nl
type
label
Death receptor-3, a new E-Sele ...... ng p38 and ERK MAPK activation
@ast
Death receptor-3, a new E-Sele ...... ng p38 and ERK MAPK activation
@en
Death receptor-3, a new E-Sele ...... ng p38 and ERK MAPK activation
@nl
prefLabel
Death receptor-3, a new E-Sele ...... ng p38 and ERK MAPK activation
@ast
Death receptor-3, a new E-Sele ...... ng p38 and ERK MAPK activation
@en
Death receptor-3, a new E-Sele ...... ng p38 and ERK MAPK activation
@nl
P2093
P3181
P1433
P1476
Death receptor-3, a new E-Sele ...... ng p38 and ERK MAPK activation
@en
P2093
Chantale Morin
François Houle
Jacques Huot
Stéphanie Gout
P304
P3181
P356
10.1158/0008-5472.CAN-05-4605
P407
P577
2006-09-15T00:00:00Z